Glioma, recurrent high grade

Clinical trials for Glioma, recurrent high grade explained in plain language.

Never miss a new study

Get alerted when new Glioma, recurrent high grade trials appear

Sign up with your email to follow new studies for Glioma, recurrent high grade, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a new pill reach brain tumors and halt their growth?

Disease control Not yet recruiting

This early-phase trial tests an experimental drug called NST-628 in adults with recurrent grade 4 glioma, an aggressive brain cancer. The study aims to see how well the drug enters the tumor and affects cancer-related proteins, as well as its safety. Participants take the drug be…

Matched conditions: GLIOMA, RECURRENT HIGH GRADE

Early phase 1 • Sponsor: Nader Sanai • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC

Glioma, recurrent high grade

Get alerted when new Glioma, recurrent high grade trials appear

Can a new pill reach brain tumors and halt their growth?